Monashee Investment Management LLC Stoke Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.12 - $14.17 $278,446 - $957,665	67,584 New	67,584 $912,000
Q1 2021 May 14, 2021	SELL	$36.08 - $69.81 $721,600 - $1.4 Million	-20,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$33.62 - $61.93 $672,400 - $1.24 Million	20,000 New	20,000 $1.24 Million
Q3 2019 Nov 12, 2019	SELL	$20.53 - $37.72 $1.53 Million - $2.81 Million	-74,621 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$25.53 - $29.17 $1.91 Million - $2.18 Million	74,621 New	74,621 $2.18 Million

117

55.6M

14K

8.8K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $482M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.